SMAD2 and cancer: Given that Smad2/3 activation is associated with the expression of MMP2, a key mediator of cancer metastasis [40,41], we examined MMP2 levels and found that AML-exos upregulated MMP2 expression in Thp-1 cells, which was reversed by ITD1 (Figure 6B).